HF
EDIT icon

HRT Financial’s Editas Medicine EDIT Stock Holding History

HRT Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,515
Closed -$35K – 4497
2026
Q1 		$35K Buy
+14,515
New +$30.7K ﹤0.01% 3508
2024
Q4 		– Sell
-448,297
Closed -$1.53M – 2595
2024
Q3 		$1.53M Buy
448,297
+150,267
+50% +$654K 0.01% 1006
2024
Q2 		$1.39M Buy
+298,030
New +$1.68M 0.01% 865
2024
Q1 		– Sell
-143,401
Closed -$1.45M – 2493
2023
Q4 		$1.45M Buy
143,401
+130,049
+974% +$1.14M 0.01% 805
2023
Q3 		$104K Buy
+13,352
New +$114K ﹤0.01% 1944
2022
Q4 		– Sell
-164,713
Closed -$2.02M – 2619
2022
Q3 		$2.02M Buy
+164,713
New +$2.57M 0.02% 598
2022
Q1 		– Sell
-32,537
Closed -$863K – 3277
2021
Q4 		$863K Buy
+32,537
New +$1.12M 0.01% 1258

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HRT Financial's EDIT Position: Q2 2026 in Review

HRT Financial sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 14,515 shares — an estimated $35K sold.

HRT Financial first reported a position in EDIT in Q4 2021 and held it in 7 quarters. The position peaked at $2.02M in Q3 2022. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • HRT Financial reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 14,515 Editas Medicine shares in Q2 2026, an estimated $35K.
  • HRT Financial first reported a position in Editas Medicine in Q4 2021 and held it in 7 quarters.
  • HRT Financial's Editas Medicine position peaked at $2.02M in Q3 2022.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.